Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Omega 3 Found to Improve Behavior in Children with ADHD

By LabMedica International staff writers
Posted on 03 Nov 2014
Supplements of the fatty acids omega 3 and 6 can help children and adolescents who have a specific kind of have attention deficit hyperactivity disorder (ADHD). More...
Moreover, these findings indicate that a customized cognitive training program can improve problem behavior in children with ADHD.

Statistics show that 3%–6% of all school age children are estimated to have attention deficit hyperactivity disorder (ADHD), which entails a difficulty controlling impulses and sitting still, temper, waiting, or being attentive for more than short periods at a time. There are various kinds of ADHD where disturbances in hyperactivity, attention, and impulsivity have varying degrees of prominence. ADHD is regularly treated with stimulant medications, which are effective for most, but do not work for everyone.

In this study, 75 children and adolescents with ADHD were given either the fatty acids omega 3 and 6 or a placebo over three months, and then they were all given omega 3/6 over three months. The study was conducted double-blind, which means that neither the researchers nor the participants were allowed to know whether they received the active capsules until afterwards.

“For the group as a whole, we did not see any major improvement, but in 35% of the children and adolescents who have the inattentive subtype of ADHD called ADD, the symptoms improved so much that we can talk about a clinically relevant improvement,” said Mats Johnson, doctoral student from the Sahlgrenska Academy at the University of Gothenburg (Sweden), The findings of the study were part of Mr. Johnson’s dissertation.

The levels of omega 3 and omega 6 were also measured in blood samples, where those who had a clear improvement of their symptoms also showed a better balance between the blood levels of these two fatty acids. The dissertation also indicated that a cognitive training technique called collaborative problem solving (CPS) can be a good option or complement in the treatment of ADHD and oppositional defiant disorder (ODD).

With this approach, the children and the family receives help in training cognitive ability and solving problematic situations. The study included 17 children, whose families received up to ten weeks of CPS sessions. The families were then asked how much the behavioral problems improved directly after the treatment as well as six months afterwards. “Our study of CPS as a treatment for ADHD and ODD is the first in Sweden. All families in our study completed the treatment, and half of them experienced a large or very large improvement of the behavioral problems,” said Mr. Johnson.

The patient group that still had severe ADHD symptoms when the CPS treatment was finished was given the chance to supplement treatment with stimulants medication. In a follow-up six months later, 81% of all of the participating families experienced a large or very large improvement.

According to Mr. Johnson, this indicates that CPS can improve problem-creating behavior in children ADHD and ODD, and that children with severe ADHD symptoms can be improved using a combination of CPS and ADHD medication.

Related Links:

Sahlgrenska Academy at the University of Gothenburg



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.